Essential Takeaways: Centessa Prescribed drugs claimed development in its orexin agonist software, spotlighting the possible of ORX750 to treat narcolepsy and other rest-wake diseases centered on promising preclinical details. ORX750 demonstrated usefulness in cutting down … [Read more...]
Nyxoah Prepares to Unveil OSA Neurostimulation Study Results
Nyxoah SA announced the upcoming release of efficacy and safety data from the DREAM US pivotal study on the Genio neurostimulation system for obstructive sleep apnea (OSA). The results are expected by early April, according to the company’s fourth-quarter and full-year 2023 … [Read more...]